

|
|
Tick-borne illnesses, including Lyme disease and Rocky Mountain spotted fever, are becoming increasingly common in the United States. Presentations of various tick-borne illnesses are sometimes nonspecific, but timely and effective diagnosis are critical for optimal outcomes. Urgent care clinicians play an important role in identifying and treating tick-borne illnesses. This issue discusses the diagnosis of the tick-borne illnesses most commonly seen in urgent care settings in the United States, including the key clinical findings of the history and physical examination, and diagnostic testing options. Tick removal technique, indications for prophylactic treatment, and treatment recommendations for specific tick-borne illnesses are also reviewed.
How would you manage these patients? Subscribe for evidence-based best practices and to discover the outcomes.

Subscribe to access the complete flowchart to guide your clinical decision making.
Buy this issue and
Following are the most informative references cited in this paper, as determined by the authors.
5. Tick-Borne Disease Working Group, US Department of Health and Human Services. Tick-borne disease. 2018. Accessed May 10, 2023. (Expert recommendation)
11. * US Centers for Disease Control and Prevention. Ticks. Updated October 21, 2021. Accessed May 10, 2023. (Public health recommendations)
12. US Centers for Disease Control and Prevention. Tick surveillance. Updated November 8, 2022. Accessed May 10, 2023. (Public health surveillance data)
13. US Centers for Disease Control and Prevention. Lifecycle of blacklegged ticks. Updated November 11, 2011. Accessed May 10, 2023. (Expert recommendations)
18. Connecticut Department of Public Health. Summary of tick testing for 2021. Accessed May 10, 2023. (Analysis of surveillance data)
23. Centers for Disease Control and Prevention. Lyme disease data and surveillance. Updated August 29, 2022. Accessed May 10, 2023. (Expert recommendations)
31. National Institutes of Health, National Institute of Allergy and Infectious Diseases. History of Rocky Mountain Labs (RML). Updated March 31, 2022. Accessed May 10, 2023. (Online review)
46. US Centers for Disease Control and Prevention. Tularemia. Updated December 13, 2018. Accessed May 10, 2023.(Public health recommendations)
67. * Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease. Arthritis Care Res (Hoboken). 2021;73(1):1-9. (Professional society recommendations) DOI: 10.1002/acr.24495
70. US Centers for Disease Control and Prevention. Preventing tick bites on people. Updated July 1, 2020.(Expert recommendation)
80. US Centers for Disease Control and Prevention. Lyme disease diagnosis and testing. Updated May 21, 2021. Access May 10, 2023. (Expert recommendations)
101. US Centers for Disease Control and Prevention. Lyme disease surveillance and available data, Updated November 15, 2022. Accessed May 10, 2023.(Public health surveillance data)
Subscribe to get the full list of 101 references and see how the authors distilled all of the evidence into a concise, clinically relevant, practical resource.
Keywords: tick-borne illness, tick-borne disease, Lyme disease, Rocky Mountain spotted fever, RMSF, STARI, babesiosis, ehrlichiosis, anaplasmosis, tularemia, tick-borne relapsing fever, Powassan, rickettsiosis, alpha-gal syndrome, erythema migrans, Ixodes, blacklegged tick, deer tick, lone star tick, dog tick, doxycycline
Keith Pochick, MD, FACEP: Editor-in-Chief Christopher Chao, MD; Kristopher W. Decker, MS, PA-C Lisa Campanella-Coppo
Margaret Carman, DNP, RN, ACNP-BC, ENP-BC, FAEN; Benjamin Silverberg, MD, MSc, FAAFP, FCUCM
Brad Laymon, PA-C, CPC, CEMC
June 1, 2023 (Reviewed: Mar 2026)
June 1, 2029   CME Information
4 AMA PRA Category 1 Credits™. 4 AOA Category 2-A or 2-B Credits. Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 4 Infectious Disease and 1 Pharmacology CME credits